Author:
Altoum Ghadah H.,AL-Enazi Fouza K.,Abudahash Mubarl M.,AL-Fadhli Reem A.,Alenzi Naif
Abstract
AbstractMarket drugs including brand or generic with poor quality, don’t meet the acceptable standard guidelines. Vildagliptin is an important antidiabetic drugs used in monotherapy or in combinations protocols for treatment of diabetes mellites. The main goal of the current study is to assess the pharmaceutical equivalence of two marketed generics of vildagliptin 50 mg tablets compared to the branded product (Galvus 50 mg). The in vitro dissolution test was used as a quality control tool to obtain the dissolution profile of vildagliptin compared to the reference drug. The results revealed that all tested samples showed dissolution behavior like standard drug. Whole samples dissolution reached after 15 min in accordance with the standard. According to the similarity factors records, tested vildagliptin samples showed a comparable dissolution to the reference drug. The current work presents an in vitro protocol for quality evaluation of recently released generic drugs.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Nandyala, S. et al. Comparative evaluation of branded and generic medicines-ranitidine & metformin HCl. Int. Res. J. Pharmacy Med. Sci. 1, 24–28 (2018).
2. Igbinovia, M. E. The Perceived Benefits of Generic Versus Branded Medicines (University of Pretoria, 2010).
3. Stuart, A. V. et al. Comparing the dissolution profiles of seven metformin formulations in simulated intestinal fluid. Dissolut. Technol 22, 17–21 (2015).
4. Young, A. R. Generic pharmaceutical regulation in the United States with comparison to Europe: innovation and competition. Wash. U. Global Stud. L. Rev. 8, 165 (2009).
5. Shokhin, I., Ramenskaya, G., Vasilenko, G. & Malalshenko, E. Assessment of the possibility of using comparative in vitro dissolution kinetics (biowaiver) instead of in vivo bioequivalence evaluation for establishing the interchanbeability of generic drugs. Pharm. Chem. J. 45, 107–109 (2011).